Advanced Search
Contact | Corporate | Help

Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer

Sponsors:
  • University of California, Los Angeles
  • National Cancer Institute (NCI)
  • Genentech
  • AstraZeneca
Phases:
  • Phase II
IndicationsAcronym:
  • Breast Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: Faslodex
  • Biological: Herceptin
Enrollment:
3

Additional information about NCT00138125.


SourceSolution © 2008-2012